151. Selective accumulation of a novel antimalarial rhodacyanine derivative, SSJ-127, in an organelle of Plasmodium berghei
- Author
-
Yuko Ogawa, Masataka Ihara, Chika Arai, Mayumi Ikegami-Kawai, and Ryohei Yanoshita
- Subjects
Erythrocytes ,Plasmodium berghei ,Clinical Biochemistry ,Pharmaceutical Science ,Pyridinium Compounds ,Biology ,Mitochondrion ,Biochemistry ,Plasmodium ,Antimalarials ,Mice ,parasitic diseases ,Drug Discovery ,Organelle ,medicine ,Parasite hosting ,Animals ,Rhodamine 123 ,Benzothiazoles ,Molecular Biology ,Oxazoles ,Apicoplast ,Organic Chemistry ,biology.organism_classification ,medicine.disease ,In vitro ,Mitochondria ,Thiazoles ,Microscopy, Fluorescence ,Molecular Medicine ,Malaria - Abstract
SSJ-127, a novel antimalarial rhodacyanine derivative, has shown potent antimalarial activity against chloroquine-resistant Plasmodium strains in vitro and subcutaneous administration of SSJ-127 results in a complete cure of a mouse malaria model. SSJ-127 was detected by fluorescence microscopy in the mouse malaria parasites Plasmodium berghei after exposure of infected red blood cells to the compound in vitro and in vivo. Selective accumulation of SSJ-127 in an organelle is observed in all blood stages of live malaria parasites. The organelle is clearly different from the mitochondrion and the nucleus in terms of morphology. The shape of the organelle changed during the asexual blood stages of the parasite. There was always a close association between the organelle and the mitochondrion. These results raised the possibility that SSJ-127 accumulates in an apicoplast of the malaria parasite and affects protozoan parasite-specific pathways.
- Published
- 2010